Sovereign Health Leads the Industry in Measurement-Based Care
Independent report affirms efficacy of firm’s treatment programs
San Clemente, Calif. — According to a recent quarterly report by Harvard Medical School Affiliate McLean Hospital, Sovereign Health’s Residential and Partial Hospitalization Program patients had marked improvements in their treatment outcomes from admission to discharge,. Sovereign’s patients self-reported that their overall functional deficits and symptom severity had decreased by over 50 percent because of treatment.
McLean Hospital’s independent Quarter 4 report, which covered October through December 2016, indicated that Sovereign’s Residential Program admitted much sicker patients than other treatment centers did over the same three-month period, and that participants in the program achieved a 52 percent reduction in overall symptom severity and functional difficulty from admission to discharge. The national average for the same domain, per the report, was 37 percent.
Sovereign Health received outstanding scores in all symptom domains, outperforming 50 other Joint Commission-accredited treatment networks. In addition, the data showed that Sovereign’s performance was especially impressive regarding treatment outcomes surrounding patients’ overall mental health and well-being.
The recent results confirm a consistent track record of superior clinical care provided by Sovereign Health. McLean’s Quarter 3 report (covering July through September 2016) also detailed that patients treated by Sovereign experienced marked improvement in their symptoms and functional deficits from admission to discharge.
“We continuously monitor and evaluate our services and clinical outcomes. I am delighted to see that these data validate Sovereign’s commitment to providing the highest quality clinical care to patients with mental health and substance use disorders,” said Sovereign Health’s Chief Scientific Officer Veena Kumari, Ph.D.
The Joint Commission is the nation’s leading health care standards-setting and accrediting organization. Sovereign has qualified for the Joint Commission’s Gold Seal of Approval for several years. The company’s extensive national network of nine facilities across five states also enjoys the distinction of being accredited to provide concurrent mental health and substance use treatment, a rarity in the field.
For more information about McLean’s Quarter 4 results for Sovereign Health, please visit Sovereign Health’s eBASIS webpage.
From the outset, Sovereign Health has fashioned its treatment programs to deliver high-quality care for substance use and behavioral health issues; the company has always based its treatment plans on measurement-based care to ensure clinical efficacy and the best outcomes for all patients. Measurement-based care is the practice of periodically monitoring clinical progress and obtaining patient feedback on specific measures to improve the quality and effectiveness of treatment, and to deliver care that is tailor-made to meet each patient’s individual needs.
The two independent quarterly reports from McLean Hospital confirm that Sovereign Health provides a higher quality of patient care relative to the care provided by 50 other Joint Commission-accredited organizations across the country and confirms that Sovereign is meeting its commitment to provide cutting-edge and comprehensive treatment to every patient that passes through its doors.
About Sovereign Health
Sovereign Health’s mission is to provide a broad spectrum of high-quality behavioral health treatment services for adults and adolescents, including support services for family members. One factor that differentiates Sovereign from other treatment providers has been the company’s ability to offer separate mental health and addiction or dual diagnosis treatment programs at its facilities. For more information, visit www.sovhealth.com.